BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3788316)

  • 1. [S phase fraction and immunohistologic demonstration of the epithelial marker MAM-6 in orofacial tumors].
    Kunz J; Ruschin P; Zotter S
    Zentralbl Allg Pathol; 1986; 132(3):233-42. PubMed ID: 3788316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma.
    Santos-García A; Abad-Hernández MM; Fonseca-Sánchez E; Julián-González R; Galindo-Villardón P; Cruz-Hernández JJ; Bullón-Sopelana A
    Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E100-5. PubMed ID: 16505783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferation kinetics of tumor cells. Histoautoradiographic studies of squamous cell carcinomas of the cervix uteri in the human].
    Kunz J; Banaschak A
    Acta Histochem Suppl; 1984; 30():111-6. PubMed ID: 6425931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas.
    Vigneswaran N; Peters KP; Hornstein OP; Haneke E
    J Oral Pathol Med; 1989 Aug; 18(7):377-90. PubMed ID: 2479742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ha-ras oncogene product in human oral squamous cell carcinoma.
    Oku N; Shimada K; Itoh H
    Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of epithelial cell activity in patients with oral cancer.
    Thomson PJ; Potten CS; Appleton DR
    Br J Oral Maxillofac Surg; 1999 Oct; 37(5):384-90. PubMed ID: 10577753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
    Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
    Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
    Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
    Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-phase fraction of human tumors and preneoplasia.
    Kunz J
    Folia Histochem Cytobiol; 1990; 28(3):121-8. PubMed ID: 1965718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of DNA methyltransferases 1, 3a and 3b in oral leukoplakias and squamous cell carcinomas.
    Daniel FI; Rivero ER; Modolo F; Lopes TG; Salum FG
    Arch Oral Biol; 2010 Dec; 55(12):1024-30. PubMed ID: 20951977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostacyclin (PGI2) biosynthetic activity in variously differentiated neoplasms and the surrounding tissue].
    Schulz S; Mentz P; Timmel H; Giessler C
    Zahn Mund Kieferheilkd Zentralbl; 1989; 77(8):811-4. PubMed ID: 2534016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma].
    Jiang Y; Wu Y; Wang F
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma.
    Fillies T; Jogschies M; Kleinheinz J; Brandt B; Joos U; Buerger H
    Oncol Rep; 2007 Sep; 18(3):639-43. PubMed ID: 17671713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy analysis in oral carcinogenesis.
    de Lima TB; Paz AHR; Rados PV; Leonardi R; Bufo P; Pedicillo MC; Santoro A; Cagiano S; Aquino G; Botti G; Pannone G; Visioli F
    Pathol Res Pract; 2017 Sep; 213(9):1072-1077. PubMed ID: 28843750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in premalignant and malignant lesions of human oral mucosa.
    Kannan S; Tahara H; Yokozaki H; Mathew B; Nalinakumari KR; Nair MK; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):413-20. PubMed ID: 9184774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA analysis of oral leukoplakia by flow cytometry.
    Saito T; Notani K; Miura H; Fukuda H; Mizuno S; Shindoh M; Amemiya A
    Int J Oral Maxillofac Surg; 1991 Oct; 20(5):259-63. PubMed ID: 1761874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of cellular kinetics in oral leukoplakia].
    Abati S; Sardella A; Costa A; Carrassi A
    Dent Cadmos; 1990 Jul; 58(12):68-74. PubMed ID: 2209940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell kinetics of oral leukoplakia].
    Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Mar; 26(2):81-3, 126-7. PubMed ID: 1874071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
    Scheifele C; Schlechte H; Bethke G; Reichart PA
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.